Skip to main content
. 2021 Nov;195:105177. doi: 10.1016/j.antiviral.2021.105177

Fig. 1.

Fig. 1

Location of identified mutated residues corresponding to the residues in hRV2 VP1 protein in complex with Vapendavir. VP1 protein in blue. Pocket surface in grey with drug-interacting residues in yellow. Residues mutated in resistant populations represented in sticks and balls.